Literature DB >> 1274371

Bile and urine as complementary pathways for the excretion of foreign organic compounds.

P C Hirom, P Millburn, R L Smith.   

Abstract

1. The urinary and biliary excretion in the rat of 30 aromatic compounds with mol. wt. of 100-850, and largely excreted unchanged, has been studied. 2. These compounds fall into three groups as regards their pattern of elimination, which is related to mol. wt: group 1, with mol. wt. less than 350 and the major route of elimination the urine. When urinary excretion is prevented by ligating the renal pedicles the biliary excretion remains low. group 2, with mol, wt. of 450-850 which are excreted predominantly in bile. Even when the bile duct is obstructed, only small amounts of these compounds are found in urine. group 3, with mol. wt. of 350-450, which are eliminated extensively in both urine and bile. When one of these routes is blocked excretion by the other increases. 3. These studies emphasize the interrelationship of urine and bile as excretory routes for organic compounds. Urine and bile are complementary pathways; the extent of urinary excretion is greatest for the compounds of lowest mol. wt. and tends to decrease as mol. wt. increases and biliary excretion becomes more extensive.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1274371     DOI: 10.3109/00498257609151612

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  17 in total

Review 1.  Drug uptake systems in liver and kidney: a historic perspective.

Authors:  B Hagenbuch
Journal:  Clin Pharmacol Ther       Date:  2009-11-18       Impact factor: 6.875

2.  Kinetics of 35S-perazine in the bile fistula rat.

Authors:  U Breyer; I Jahns; G Irmscher; H Rassner; S Rehmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  Influence of impaired renal function on the disposition of [14C]fazadinium in the anaesthetized greyhound [proceedings].

Authors:  D R Bevan; J Caldwell; J D'Souza; R L Smith
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

4.  Comparison of two different biliary agents in healthy subjects and in patients with liver disease.

Authors:  R Dudczak; K Kletter; P Angelberger; H Frischauf
Journal:  Eur J Nucl Med       Date:  1979-10

5.  The metabolic and pharmacokinetic disposition of mebendazole in the rat.

Authors:  R J Allan; T R Watson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

Review 6.  Organic anion uptake by hepatocytes.

Authors:  Allan W Wolkoff
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  Elimination of roquefortine in the rat.

Authors:  I Laws; P G Mantle
Journal:  Mycotoxin Res       Date:  1987-03       Impact factor: 3.833

8.  99mTc-diethyl-HIDA: a contribution to the study of its structure.

Authors:  U Fonda; B Pedersen
Journal:  Eur J Nucl Med       Date:  1978-04-01

9.  Pharmacokinetics and biliary excretion of bromosulphophthalein, [3H]-ouabain and [3H]-taurocholic acid in rats with glycerol-induced acute renal failure.

Authors:  C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

Review 10.  Biliary excretion of drugs in man.

Authors:  D E Rollins; C D Klaassen
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.